Home/Filings/4/0000950170-25-082456
4//SEC Filing

COLA MICHAEL F 4

Accession 0000950170-25-082456

CIK 0001783183other

Filed

Jun 4, 8:00 PM ET

Accepted

Jun 5, 4:58 PM ET

Size

7.5 KB

Accession

0000950170-25-082456

Insider Transaction Report

Form 4
Period: 2025-06-03
Transactions
  • Award

    Common Stock

    2025-06-03+10,50039,798 total
  • Award

    Stock Option (Right to Buy)

    2025-06-03+17,50017,500 total
    Exercise: $4.95Exp: 2035-06-02Common Stock (17,500 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units ("RSUs") were granted on June 3, 2025, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to Reporting Person's continuing in service on the Board through such vesting date.

Documents

1 file

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1
  • filerCIK 0001188940

Filing Metadata

Form type
4
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:58 PM ET
Size
7.5 KB